These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 12614563)

  • 21. Brain tumor eradication and prolonged survival from intratumoral conversion of 5-fluorocytosine to 5-fluorouracil using a nonlytic retroviral replicating vector.
    Ostertag D; Amundson KK; Lopez Espinoza F; Martin B; Buckley T; Galvão da Silva AP; Lin AH; Valenta DT; Perez OD; Ibañez CE; Chen CI; Pettersson PL; Burnett R; Daublebsky V; Hlavaty J; Gunzburg W; Kasahara N; Gruber HE; Jolly DJ; Robbins JM
    Neuro Oncol; 2012 Feb; 14(2):145-59. PubMed ID: 22070930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
    Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
    Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beyond oncolytic virotherapy: replication-competent retrovirus vectors for selective and stable transduction of tumors.
    Dalba C; Klatzmann D; Logg CR; Kasahara N
    Curr Gene Ther; 2005 Dec; 5(6):655-67. PubMed ID: 16457654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue-specific transcriptional targeting of a replication-competent retroviral vector.
    Logg CR; Logg A; Matusik RJ; Bochner BH; Kasahara N
    J Virol; 2002 Dec; 76(24):12783-91. PubMed ID: 12438603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-selective gene expression in a hepatic metastasis model after locoregional delivery of a replication-competent retrovirus vector.
    Hiraoka K; Kimura T; Logg CR; Kasahara N
    Clin Cancer Res; 2006 Dec; 12(23):7108-16. PubMed ID: 17145835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo transfer of the human interleukin-2 gene: negative tumoricidal results in experimental brain tumors.
    Ram Z; Walbridge S; Heiss JD; Culver KW; Blaese RM; Oldfield EH
    J Neurosurg; 1994 Mar; 80(3):535-40. PubMed ID: 8113867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of a semi-replicative gene delivery system allowing propagation of complementary defective retroviral vectors.
    Trajcevski S; Solly SK; Frisén C; Trenado A; Cosset FL; Klatzmann D
    J Gene Med; 2005 Mar; 7(3):276-87. PubMed ID: 15515136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined antitumor effects of an adenoviral cytosine deaminase/thymidine kinase fusion gene in rat C6 glioma.
    Chang JW; Lee H; Kim E; Lee Y; Chung SS; Kim JH
    Neurosurgery; 2000 Oct; 47(4):931-8; discussion 938-9. PubMed ID: 11014433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved herpes simplex virus type 1 amplicon vectors for proportional coexpression of positron emission tomography marker and therapeutic genes.
    Jacobs AH; Winkeler A; Hartung M; Slack M; Dittmar C; Kummer C; Knoess C; Galldiks N; Vollmar S; Wienhard K; Heiss WD
    Hum Gene Ther; 2003 Feb; 14(3):277-97. PubMed ID: 12639307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody-mediated targeting of replication-competent retroviral vectors.
    Tai CK; Logg CR; Park JM; Anderson WF; Press MF; Kasahara N
    Hum Gene Ther; 2003 May; 14(8):789-802. PubMed ID: 12804141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imaging expression of adenoviral HSV1-tk suicide gene transfer using the nucleoside analogue FIRU.
    Nanda D; de Jong M; Vogels R; Havenga M; Driesse M; Bakker W; Bijster M; Avezaat C; Cox P; Morin K; Naimi E; Knaus E; Wiebe L; Smitt PS
    Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):939-47. PubMed ID: 12212546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiosensitization of gliomas by intracellular generation of 5-fluorouracil potentiates prodrug activator gene therapy with a retroviral replicating vector.
    Takahashi M; Valdes G; Hiraoka K; Inagaki A; Kamijima S; Micewicz E; Gruber HE; Robbins JM; Jolly DJ; McBride WH; Iwamoto KS; Kasahara N
    Cancer Gene Ther; 2014 Oct; 21(10):405-410. PubMed ID: 25301172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization and transduction of a retroviral vector encoding human interleukin-4 and herpes simplex virus-thymidine kinase for glioma tumor vaccine therapy.
    Okada H; Attanucci J; Tahara H; Pollack IF; Bozik ME; Chambers WH; Lotze MT
    Cancer Gene Ther; 2000 Mar; 7(3):486-94. PubMed ID: 10766355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of progressive or recurrent pediatric malignant supratentorial brain tumors with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration.
    Packer RJ; Raffel C; Villablanca JG; Tonn JC; Burdach SE; Burger K; LaFond D; McComb JG; Cogen PH; Vezina G; Kapcala LP
    J Neurosurg; 2000 Feb; 92(2):249-54. PubMed ID: 10659011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic gene delivery of interferon-inducible protein 10 through replication-competent retrovirus vectors suppresses tumor growth.
    Sun Y; Finger C; Alvarez-Vallina L; Cichutek K; Buchholz CJ
    Cancer Gene Ther; 2005 Nov; 12(11):900-12. PubMed ID: 15905858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of PCR and ELISA assays for screening clinical trial subjects for replication-competent retrovirus.
    Martineau D; Klump WM; McCormack JE; DePolo NJ; Kamantigue E; Petrowski M; Hanlon J; Jolly DJ; Mento SJ; Sajjadi N
    Hum Gene Ther; 1997 Jul; 8(10):1231-41. PubMed ID: 9215740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous administration of retroviral replicating vector, Toca 511, demonstrates therapeutic efficacy in orthotopic immune-competent mouse glioma model.
    Huang TT; Parab S; Burnett R; Diago O; Ostertag D; Hofman FM; Espinoza FL; Martin B; Ibañez CE; Kasahara N; Gruber HE; Pertschuk D; Jolly DJ; Robbins JM
    Hum Gene Ther; 2015 Feb; 26(2):82-93. PubMed ID: 25419577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defective herpes simplex virus vectors expressing thymidine kinase for the treatment of malignant glioma.
    Miyatake S; Martuza RL; Rabkin SD
    Cancer Gene Ther; 1997; 4(4):222-8. PubMed ID: 9253507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Limited efficacy of the HSV-TK/GCV system for gene therapy of malignant gliomas and perspectives for the combined transduction of the interleukin-4 gene.
    Benedetti S; Dimeco F; Pollo B; Cirenei N; Colombo BM; Bruzzone MG; Cattaneo E; Vescovi A; Didonato S; Colombo MP; Finocchiaro G
    Hum Gene Ther; 1997 Jul; 8(11):1345-53. PubMed ID: 9295129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double suicide gene therapy using a replication defective herpes simplex virus vector reveals reciprocal interference in a malignant glioma model.
    Moriuchi S; Wolfe D; Tamura M; Yoshimine T; Miura F; Cohen JB; Glorioso JC
    Gene Ther; 2002 May; 9(9):584-91. PubMed ID: 11973634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.